Cambridge Investment Research Advisors’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q1
Sell
-39,150
Closed -$87K 2276
2017
Q4
$87K Sell
39,150
-75,375
-66% -$168K ﹤0.01% 2037
2017
Q3
$332K Sell
114,525
-34,550
-23% -$100K ﹤0.01% 1485
2017
Q2
$663K Sell
149,075
-9,000
-6% -$40K 0.01% 1033
2017
Q1
$737K Sell
158,075
-1,500
-0.9% -$6.99K 0.01% 874
2016
Q4
$972K Sell
159,575
-3,000
-2% -$18.3K 0.02% 691
2016
Q3
$896K Sell
162,575
-37,400
-19% -$206K 0.02% 737
2016
Q2
$760K Sell
199,975
-20,834
-9% -$79.2K 0.02% 742
2016
Q1
$609K Sell
220,809
-27,480
-11% -$75.8K 0.01% 793
2015
Q4
$1.41M Sell
248,289
-2,875
-1% -$16.3K 0.03% 444
2015
Q3
$1.33M Sell
251,164
-1,000
-0.4% -$5.3K 0.04% 400
2015
Q2
$2.09M Sell
252,164
-17,641
-7% -$146K 0.06% 306
2015
Q1
$1.25M Sell
269,805
-33,900
-11% -$157K 0.04% 435
2014
Q4
$926K Sell
303,705
-88,965
-23% -$271K 0.03% 517
2014
Q3
$1.09M Sell
392,670
-32,320
-8% -$90K 0.03% 485
2014
Q2
$1.73M Sell
424,990
-16,300
-4% -$66.4K 0.06% 307
2014
Q1
$2.34M Sell
441,290
-25,824
-6% -$137K 0.09% 222
2013
Q4
$2.59M Buy
467,114
+11,747
+3% +$65.2K 0.11% 178
2013
Q3
$2.05M Buy
455,367
+78,336
+21% +$353K 0.09% 214
2013
Q2
$1.61M Buy
+377,031
New +$1.61M 0.08% 228